Bispecific antibody-mediated cell surface accumulation of PEGylated asparaginase enhances therapeutic efficacy and attenuates stromal protection in CD20-positive lymphoma
Translational Research
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Cite
Get new articles on “Biochemistry (medical)”
Subscriptions, keyword tracking and favourites — in the Articlium Telegram bot.
Open in Telegram
Citation
✕
ГОСТ
APA
MLA
BibTeX
Bispecific antibody-mediated cell surface accumulation of PEGylated asparaginase enhances therapeutic efficacy and attenuates stromal protection in CD20-positive lymphoma. // Translational Research. – URL: https://www.sciencedirect.com/science/article/pii/S1931524426002215?dgcid=rss_sd_all
Bispecific antibody-mediated cell surface accumulation of PEGylated asparaginase enhances therapeutic efficacy and attenuates stromal protection in CD20-positive lymphoma. Translational Research. https://www.sciencedirect.com/science/article/pii/S1931524426002215?dgcid=rss_sd_all
“Bispecific antibody-mediated cell surface accumulation of PEGylated asparaginase enhances therapeutic efficacy and attenuates stromal protection in CD20-positive lymphoma.” Translational Research.
@article{article69967,
title = {Bispecific antibody-mediated cell surface accumulation of PEGylated asparaginase enhances therapeutic efficacy and attenuates stromal protection in CD20-positive lymphoma},
journal = {Translational Research},
url = {https://www.sciencedirect.com/science/article/pii/S1931524426002215?dgcid=rss_sd_all}
}